13D Filing: Delphi Ventures VIII LP and Karyopharm Therapeutics Inc. (KPTI)

Page 11 of 12

Page 11 of 12 – SEC Filing

CUSIP NO.   48576U106 13D Page 11 of 12
JAMES J. BOCHNOWSKI
DAVID L. DOUGLASS
DEEPIKA R. PAKIANATHAN
DOUGLAS A. ROEDER
By: /s/ Matthew T. Potter
Name: Matthew T. Potter
Title: Chief Financial Officer/Attorney-In-Fact

* Signed pursuant to a Power of Attorney already
on file with the appropriate agencies.

Follow Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Page 11 of 12